2m 2m 2m 2m 2m 2m 2m
SURROZEN (SRZN)
NASDAQ
$29.54-$0.46 (-1.55%)
Price as of Oct 02, 2026 4:39 PM EDT- $352.6MMarket Cap
- 117.86%1-Year Change
- BiotechnologyIndustry
SURROZEN (SRZN)
$29.54-$0.46 (-1.55%)
SRZN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $30.00 | ||
Change | -$2.18 (-6.77%) | ||
Open | $31.60 | ||
High | $32.00 | ||
Low | $29.72 | ||
Previous Close | $32.18 | ||
Volume | 438,530 | ||
30-Day Average Volume | 872,934 | ||
1-Week Change | -10.93% | ||
1-Month Change | 35.14% | ||
1-Year Change | 117.86% | ||
3-Year Change | 308.16% | ||
5-Year Change | -71.99% | ||
Fundamentals | |||
Shares Outstanding | 11.8M | ||
Total Assets | $115.6M | ||
Market Cap | $352.6M | ||
Enterprise Value | $250.6M | ||
Period: QTR TTM FY | |||
Revenue | $5.0M | ||
Net Income | $50.2M | ||
Free Cash Flow | -$7.4M | ||
EBIT | $50.2M | ||
EBITDA | $50.2M | ||
Net Working Capital | $100.4M | ||
EPS | -$0.41 | ||
Enterprise Value/EBITDA | 5 | ||
Enterprise Value/Revenue | 50 | ||
P/B | -2 | ||
P/E | -73 | ||
PEG | -1 | ||
Price/Free Cash Flow | -47 | ||
Price/Operating Cash Flow | -48 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 12/14/2023 | ||
Earnings & Revenue